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In this study, free porcine hepatocytes suspension (Group A), porcine hepatocytes embedded in collagen gel (Group B), porcine
hepatocytes cultured with PLA-O-CMC nanoparticles and embedded in collagen gel (Group C), and PLA-O-CMC nanoparticles
alone (Group D) were transplanted into peritoneal cavity of ALF rats, respectively. The result showed that plasma HGF levels were
elevated post-transplantationwith a peak at 12hr. The rats in Group C showed highest plasma HGF levels at 2, 6, 12, 24 and 36hr
post-transplantation and lowest HGF level at 48hr. Plasma VEGF levels were elevated at 48hr post-transplantation with a peak
at 72hr. The rats in Group C showed highest plasma HGF levels at 48, 72, and 96hr post-transplantation. The liver functions
in Group C were recovered most rapidly. Compared with Group B, Group C had signiﬁcant high liver Kiel 67 antigen labeling
index (Ki-67 LI) at day 1 post-HTx (P<. 05). Ki-67 LI in groups B and C was higher than that in groups A and D at days 5 and
7 post-HTx. In conclusion, intraperitoneal transplantation of porcine hepatocytes cultured with PLA-O-CMC nanoparticles and
embedded in collagen gel can promote signiﬁcantly liver regeneration in ALF rats.
1.Introduction
Acute Liver Failure (ALF) is a life-threatening clinicopatho-
logical condition with a high rate of fatality. Impaired
liver regeneration is one of the most critical issues in
the prognosis. Because of the larger potential regeneration
capacity of liver, temporary and eﬀective liver function
support will make the patients with ALF have time to wait
for liver transplantation and have the possibility of recovery
through the regeneration of remaining hepatocytes. Hepato-
cytes transplantation (HTx) is anticipated to be an eﬀective
methodtosubstituteliverfunctions [1,2].Butbecauseofthe
shorter survival time of transplanted hepatocytes, emphasis
in study of HTx has been put on getting the better functions
of transplanted hepatocytes and the better liver regener-
ation of ALF recipients. Nanomaterial scaﬀold is helpful
to adherence, proliferation, and diﬀerentiated functions of
cells [3]. In our previous study, we found that hepatocytes
could proliferate rapidly and represent better functions on
nanomaterial scaﬀold [4]. In this study, porcine hepatocytes
cultured with polylactic acid-O-carboxymethylated chitosan
(PLA-O-CMC) nanoparticles and embedded in collagen gel
were transplanted into the peritoneal cavity of ALF rats to
study the liver regeneration reaction.
Hepatocytegrowth factor(HGF)isa multipotentgrowth
factor that is a powerful stimulator of DNA synthesis in
a variety of cell types, especially hepatocytes [5]. HGF
plays a key role in the regulation of liver regeneration
after hepatocyte damage. It was reported that HGF activity
increases in proportion to the decrease in functional liver
mass before the initiation of liver regeneration and rapidly
decreases to near normal levelsafter recovery [6]. Changesin
HGF production reﬂect the status of regeneration process.
Vascular endothelial growth factor (VEGF) is a strongest
factor in a number of known endogenous factors promoting
vessel regeneration. VEGF derived from hepatocytes is
associated with processes of liver regeneration. HTx has
been used by many investigators to demonstrate metabolic2 Journal of Drug Delivery
support and improve survival in rats with ALF. However,
few of these reports have examined the impact of cell
therapy on the regenerative response in the native liver.
To our knowledge, there was no detailed study about liver
regeneration response in HTx with nanomaterials. In the
present study, levels of HGF and VEGF, albumen (ALB),
alanine aminotransferase (ALT), total bilirubin (TB), and
NH3 in the plasma and liver Kiel 67 antigen labeling index
(Ki-67 LI) of ALF rats after HTx were observed. The
aim of the present study was to investigate the eﬀect of
transplantation of porcine hepatocytes cultured with PLA-
O-CMC nanoparticles and embeddedin collagen gel on liver
regeneration in ALF rats.
2.Materialsand Methods
2.1. Animals. Chinese experimental miniature pigs (n = 5,
male and female, body weight 2 to 4Kg), Sprague-Dawley
rats (n = 220, male and female, weight 250 to 280g)
were supplied by Experimental Animal Center of Nantong
University.Alloperationswereperformedbetween9AMand
noon. The pigs and rats were allowed free access to water
and were fasted for 12hr before experiment. The research
protocol was in compliance with Chinese guidelines for
the humane care of experimental animals. The study was
approved by the hospital ethics committee.
2.2.Reagents. D-galactosamine (D-Gal)was purchased from
the Department of Chemistry, Chongqing Medical Univer-
sity, China. Collagenase IV, RPMI1640, new-born bovine
serum (NBS), and HGF were purchased from Gibco BRL,
Life Technologies, USA. Polylactic acid was from Sigma
Chemical Co., USA (St. Louis, MO). O-carboxymethylated
chitosan was from Weikang Biotechnology Company Lim-
ited, Shanghai, China.
2.3. Preparation of PLA-O-CMC Nanoparticles. PLA-O-
CMC nanoparticles were prepared with polylactic acid and
O-carboxymethylated chitosan by u1trasonic method as
described previously [7].
2.4. ALF Rat Model and Groups. 10% D-Gal was injected
into the peritoneal cavity of Sprague-Dawley rats at 1.2g/Kg.
The rats (n = 165) were divided randomly into four
groups: simple hepatocyte transplantation group (Group A),
collagen and hepatocyte transplantation group (Group B),
and nanoparticles, collagen, and hepatocyte transplantation
group (Group C), and nanoparticles transplantation group
(Group D).
2.5. Porcine Hepatocyte Culture. Porcine hepatocytes were
isolated by an in situ recirculating collagenase perfusion
method as described previously [8–11]. The yield of hep-
atocytes was (4.5∼5.0) × 107/g. The mean viability of
hepatocytes was 97% by trypan blue exclusion. The isolated
hepatocytes were suspended in RPIM1640 medium supple-
mented with 10% NBS, 200μg/L hydrocortisone, 100μg/L
insulin, 200μg/L HGF, 100000U/L penicillin, and 100μg/L
streptomycin. The isolated hepatocytes were divided into
three groups and incubated at 5 × 106/mL in 5% CO2
atmosphere with 100% humidity at 37◦C. Group A: isolated
hepatocytes were cultured for 24hr. In the ﬁrst 12hr, the
hepatocytesuspensions were agitatedfor 5min every30min.
Then they were centrifugated at 800rpm and hepatocytes
were resuspended in the above medium for 12hr. 5mL hep-
atocyte suspensions with 1 × 107 cells/mL were transplanted
into the peritoneal cavity of ALF rats. Group B: isolated
hepatocytes were cultured for 12hr and agitated for 5min
every 30min. Then they were centrifugated at 800rpm and
hepatocytes were resuspended in the above medium. The
hepatocytesuspensions with4 ×107 cells/mL,collagentypeI
(0.4% collagen type in 0.1N acetic acid), 10 × RPMI1640,
100% NBS, and 1NNaOH were mixed. The volume ratio of
theaboveﬁvecomponentswas2.5:5:1:1:0.5.Theﬁnalcol-
lagen concentration was 2mg/mL, the density of hepatocytes
was 1 × 107/mL, and pH of solution was 7.4. The mixture
was dropped into 6-well cell culture plates at 5mL for every
well and cultured in 5% CO2 incubator at 37◦C. Porous gel
was formed after 2 to 3hr. Then 5mL RPMI1640 medium
was added to make the gel suspended in the medium. The
hepatocyte suspensions were further cultured in 5% CO2
incubator at 37◦C .T h et o t a lc u l t u r et i m ea f t e rc o l l a g e n
additionwas12hr.Atlast,thegelcontaininghepatocyteswas
transplanted into the peritoneal cavity of ALF rats. Group C:
isolated hepatocytes were cultured with 100mg/L PLA-O-
CMC nanoparticles for 12hr and agitated for 5min every
30min. Then the medium was centrifugated at 800rpm and
hepatocytes were resuspended in the above medium. The
hepatocyte suspensions, collagen type I, 10 × RPMI1640,
100% NBS, and 1N NaOH were mixed in the same method
as Group B. The ﬁnal collagen concentration was 2mg/mL,
the density of hepatocytes was 1 × 107/mL, concentration of
the nanoparticles was 100mg/L, and pH of solution was 7.4.
Themixturewasdroppedinto6-ellcellcultureplatesat5mL
for every well and cultured in 5% CO2 incubator at 37◦C.
Porousgelwasformedafter2-3hr. Then RPMI1640medium
was added to make the gel suspended in the medium. The
hepatocyte suspensions were further cultured in 5% CO2
incubator at 37◦C .T h et o t a lc u l t u r et i m ea f t e rc o l l a g e n
additionwas12hr.Atlast,thegelcontaininghepatocyteswas
transplanted into the peritoneal cavity of ALF rats.
2.6. HTx. HTx was done in Sprague-Dawley rats at 48hr
after D-gal injection. Under ether anesthesia, the abdomen
cavity was opened through median incision of abdomen.
In Group A, hepatocyte suspensions were injected into the
lesser omentum sac of ALF rats. In Groups B and C, gel
containing hepatocytes and gel containing hepatocytes cul-
turedwithnanoparticleweretransplantedintotheperitoneal
cavity of ALF rats and wrapped up with greater omentum,
respectively. The total number of transplanted hepatocytes
was 5 × 107. In Group D, 100mg/L PLA-O-CMC nanopar-
ticles were injected into the lesser omentum sac of ALF rats.
Abdomenwallwassuturedinlayer.Aftertransplantation,the
rats in three groups were raised in diﬀerent cages and drank
water with 10% glucose. No immunosuppressive reagents
were administered throughout the experiment.Journal of Drug Delivery 3
2.7. Determination of Plasma HGF and VEGF Levels. Plasma
HGF level was determined in batches of ﬁve rats each before
HTx and at 2, 6, 12, 24, 36, and 48hr after HTx. Plasma
VEGF levelwas determined in batchesofﬁveratseach before
HTx and at 48, 72, 84, and 96hr after HTx. Blood sample
was collected from abdominal aorta of rats and put into
the test tube with ethylene diamine tetraacetic acid (EDTA).
The samples were centrifuged at 3000rpm for 10min and
stored at −80◦C until growth factor assays were performed.
The levels of plasma HGF and VEGF were analyzed by an
enzyme-linked immunosorbent assay (kits were supplied by
FanbangCo,Dalian,China),accordingtothemanufacturer’s
protocols. All samples were tested in duplicate. The optical
density was read within 30min using enzyme mark meter set
to wavelength of 450nm and 630nm. The levels of HGF and
VEGF were calculated from a standard curve.
2.8. Determination of Liver Functions. Changes of albumen
(ALB), alanine aminotransferase (ALT), total bilirubin (TB),
and NH3 levels in the plasma were determined with an
automatic biochemical analyzer (7600-020, Hitachi, Japan).
2.9. Determination of Kiel 67 Antigen Labeling Index (Ki-67
LI). Ki-67 LI was evaluated. Immunochemistry technique
was used. The paraﬃn sections of recipients’ livers were
stained with hematoxylin. Under light microscope, 5 visual
ﬁelds were randomly selected, and the number of cells with
buﬀy nucleus among 1000 cells per visual ﬁeld was counted,
and then the percentage of cells with buﬀy nucleus was
calculated [12].
2.10. Statistical Analyses. All results were expressed as mean
± standard deviation. Statistical analyses were performed
using Stata 7.0 software. Statistical signiﬁcance was deter-
mined by analysis of variance (ANOVA) with Student’s t-
test. A P value of less than .05 was considered statistically
signiﬁcant.
3.Results
3.1. Plasma HGF Levels. Plasma HGF levels were inde-
tectable in normal rats. They were increased at 48hr after
D-Gal injection. They continued to elevate after HTx with
a distinct peak at 12hr. They gradually declined thereafter
(Figure 1). The rats in Group C showed highest plasma HGF
levels at 2, 6, 12, 24, and 36hr after HTx and lowest HGF
level at 48hr compared with other groups (P<. 05). Plasma
HGF levels at 2, 6, 12, 24, and 36hr after HTx in Group B
were higher than other groups (P<. 05).
3.2. Plasma VEGF Levels. Plasma VEGF levels were inde-
tectableat48hr after D-Gal injection. They were increased at
48hr after HTx with a distinct peak at 72hr. They gradually
declined thereafter (Figure 2). The rats in Group C showed
highest plasma VEGF levelsat 48,72, 84, and 96hr afterHTx
compared with other groups (P<. 05). Plasma VEGF levels
at 48, 72, 84, and 96hr after HTx in Group B were higher
than other groups (P<. 05).
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Figure 1: Time course of changes in plasma HGF levels in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
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Figure 2: Time course of changes in plasma VEGF levels in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
3.3. Liver Functions. At 24hr after HTx, ALB level in Group
C was higher than that in Groups A and D (P<. 05). NH3
level in groups B and C was lower than that in Groups A and
D(P<. 05).At72hrafterHTx,ALTandNH3 levelsinGroup
C were lower than those in Groups A and D (P<. 05). ALB
level in Group C was higher than that in Groups A and D
(P<. 0 5 ) .A L Tl e v e li nG r o u pCw a sl o w e rt h a nt h a ti no t h e r
groups. There was no signiﬁcance in ALB, ALT, TB, and NH3
levels between Groups A and B. At days 5 and 7 after HTx,
there were no signiﬁcance in ALB, ALT, TB, and NH3 levels
in all groups (Figures 3, 4, 5,a n d6).
3.4. Ki-67 LI in Hepatic Tissue. Figure 7 showed pathology
of livers of ALF rat at 5d after HTx under light microscopy.
Compared with Group B, Group C had signiﬁcant high Ki-
67 LI at day 1 after HTx (P<. 05). Ki-67 LI in Groups B and
C was higher than that in Groups A and D at days 5 and 7
after HTx (P<. 05) (Figure 8).4 Journal of Drug Delivery
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Figure 3: Time course of changes in plasma ALB levels in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
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Figure 4: Time course of changes in plasma ALT levels in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
4.Discussion
ALF is associated with a high mortality. Patient survival
dependsinpartontheregenerativecapacityoftheremaining
hepatocytes. Orthotopic liver transplantation has emerged
as an eﬀective treatment for ALF [13]. However, wide
application of this therapeutic modality is limited primarily
bylackofdonors,inabilitytoprocureorgansonshort notice,
and high cost. Making a decision about transplantation
depends on whether suﬃcient liver regeneration can occur
before the onset of irreversible complications of liver failure.
HTx can provide opportunity of liver regeneration for
ALF patients by liver function support. Liver regeneration
is a complex course in which many factors participate in
regulation [14]. The process of liver regeneration mainly
included three key stages. Start stage: hepatocytes in phase
G0 entered phase G1 under the regulation of TNF-α,I L -
6, and growth factors. Progress stage: hepatocytes in phase
G1 entered phase S under the regulation of cyclin-dependent
kinase system, HGF, and TGF-α. Termination stage: growth
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Figure 5: Time course of changes in plasma NH3 levels in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
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Figure 6: Time course of changes in plasma TB levels in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
of hepatocytes stopped under the regulation of TGF-β and
nandrolone phenylpropionate [15, 16].
Itwas showed thatthehepaticparenchymal cells inphase
G0 could be activated after 30min of hepatic injury and
entered the cell proliferation cycle. Their DNA synthesis
arrived at peak at 24hr. Their proliferation was completed
on the whole at 72hr. Then the structural and functional
reconstruction of liver began. After 7 to 10 days, the liver
recovered both in the volume and weight [17].
HGF has been isolated and puriﬁed from the plasma of
patientswithfulminant hepaticfailureandfromratplatelets.
It is a heterodimeric molecule composed of a 69-kD alpha
chain and a 34-kD beta chain. HGF is produced by hepatic
mesenchymal cells such as lipocyte (Ito cells), Kupﬀer cells,
and sinusoidal endothelial cells (SEC). HGF is considered
to be important in the stimulation of DNA synthesis of
hepatocytes. HGF produced in nonparenchymal liver cells
actsoninjuredparenchymalhepatocytesthroughaparacrine
mechanism via the c-met tyrosine kinase receptor in the
surface of cellular membrane. It promoted liver regeneration
by enhancing mitosis of hepatocytes, inhibiting apoptosis ofJournal of Drug Delivery 5
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Figure 7: Liver Ki-67 LI of ALF rats at 5d after HTx (×400).
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Figure 8: Time course of changes in liver Ki-67 LI in three
groups. Error bars indicate standard deviations (n = 5). Statistical
diﬀerences were determined by ANOVA using Stata 7.0 software.
hepatocytes, promoting the recovery and reconstruction of
morphology of liver tissue, and promoting growth of blood
vessel endothelium and formation of capillary. Elevated
serum HGF levels have been reported after partial liver
resection and in the settings of ALF [18, 19]. Arkadopoulos
et al. [20] induced ALF rat model by total liver resection
after transplanting hepatocytes into spleen. They found that
plasma HGF increased at 12hr after operation. In this study,
wefoundthatplasma HGFlevelswereincreasedat48hrafter
D-Gal injection, which was consistent with other reports.
Recent studies have shown that VEGF, a most potent
angiogenicfactor, playsan essentialroleinliverregeneration.
Exogenous VEGF administration is able to stimulate liver
regeneration following acute severe liver injury and partial
hepatectomy in rats [21]. It has also shown that the serum
VEGF levelsin the survivors ofALFsigniﬁcantly increased in
the recovery phases compared with corresponding levels on
admission, suggesting that VEGF plays an important role in
liver regeneration after ALF. Namisaki et al. [22]h a ss h o w n
that HGF is a potent inducer of VEGF secretion by HepG2
cells.LiverSECproliferationisinducedbyVEGFduringliver
r e g e n e r a t i o n .S h i m i z ue ta l .[ 23] found that proliferation of
liver SECs followed hepatocyte proliferation by 24 to 48hr.
This is probably related to formation of new vasculature
to supply blood to the regenerated tissue. The authors
suggested that induction of VEGF secretion by hepatocytes
may constitute a pathway, whereby HGF originating from
either nonparenchymal liver cells or distant organs not only
stimulates hepatocyte proliferation but also mediates liver
SEC proliferation and survival as an indirect angiogenic
eﬀect. In addition, VEGF produced by hepatocytes may
stimulate liver SEC to produce growth factors, including
HGF, with liver protective/proliferative eﬀects. Thus, VEGF
and HGF appear to have complementary roles in liver injury
and regeneration.
It has been shown that the VEGF expression increased
markedly during liver regeneration induced either by partial
hepatectomy or drug intoxication [23]. Akiyoshi et al. [24]
found that VEGF level correlated with Child-Pugh class of
liver function. The lower the Child-Pugh class was, the lower
the level of VEGF was. In our study, plasma VEGF levels in
every group were increased at 48hr after HTx with a peak
at 72hr. Liver regeneration involves in the reconstitution
of hepatic sinusoids. VEGF promoted proliferation of SEC6 Journal of Drug Delivery
and hepatocytes and reconstitution of hepatic sinusoids
[22]. VEGF produced eﬀect through combination with
high aﬃnity receptor, KDR/Flk-1, that is expressed almost
exclusively on the surface of SECs [25]. It was found that
VEGF expressed predominantly in periportal hepatocytes
at 48 to 72hr after partial hepatectomy. Gupta et al. [26]
transplanted the hepatocytes into the spleen of inbreeding
line, F344 rats and found that expression of VEGF could
be detected when the transplanted hepatocytes entered the
hepatic sinusoids and integrated into hepatic plates through
endothelial fenestrations after 8hr of transplantation.
Ki-67 antigen, a sensitive indicator of liver regeneration,
is involved in DNA synthesis and is closely related to cell
proliferation [27, 28]. In our study, all groups showed liver
regeneration signs at diﬀerent degrees and in diﬀerent times
after HTx, which indicated the eﬀect of HTx. The increase
of Ki-67 LI appeared earliest in Group A. Compared with
Group B, Group C had signiﬁcant higher Ki-67 LI at day 1
after HTx. Ki-67 LI in Groups B and C was higher than
that in Group A at days 5 and 7 after HTx (P<. 05). We
speculated that the increase of Ki-67 LI may be related to the
increase of plasma HGF and VEGF levels. Boudjema et al.
[29] considered that the main mechanism of raising survival
rate of ALF patients included supplying temporary liver
functionsupport, promoting remnant liverregenerationand
recoveryofliverfunctionthroughproductionofHGF.Inthis
study, HGF levels were elevated before HTx and continued
to increase after HTx with a peak at 12hr. Whether this
is caused by impaired HGF clearance, increased synthesis
at extrahepatic sites, or both remains to be seen. VEGF
level increased at 48hr after HTx with a peak at 72hr. The
results indicated that elevated blood HGF level switched
on liver regeneration. The continuous elevation of blood
HGF level promoted liverregeneration further. VEGF played
an important role in reconstitution of hepatic sinusoids.
Plasma HGF levels were decreased after 12hr following
HTx, which may be related with the increased clearance of
HGF.
In this study, plasma HGF levels during 36hrs after
HTx and VEGF levels after HTx in Group C were found
to be highest in all groups. Ki-67 LI was highest in Group
C at days 5 to 7 after HTx, which indicated the most
active liver regeneration. The improvement of liver functions
in Group C was most rapid than other groups. It was
postulated that better liver regeneration was mainly due to
thehighercytoactiveporcinehepatocytesculturedwithPLA-
O-CMC nanoparticles and embedded in collagen gel. These
hepatocytes had better eﬀect on liver function substitution
and could make livers produce more HGF and VEGF which
could promote the regeneration and restoration of injured
liver [5].
In summary, we have demonstrated that rats with ALF
triggered a regenerative response in the native liver because
of elevated plasma HGF levels after D-Gal injection and
continuous increase of HGF after HTx. Elevated plasma
VEGF after HTx was helpful in reconstitution of hepatic
sinusoids. Transplantation of porcine hepatocytes cultured
with PLA-O-CMC nanoparticles and embedded in collagen
gel promotes liver regeneration in ALF rats.
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